View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/SAMHSA | RIN: 0930-AA39 | Publication ID: Spring 2022 |
Title: Treatment of Opioid use Disorder With Extended Take Home Doses of Methadone | |
Abstract:
SAMHSA will propose to revise 42 CFR part 8 to make permanent some regulatory flexibilities for opioid treatment programs to provide extended take home doses of methadone. To facilitate this new treatment paradigm, sections of 42 CFR part 8 would require updating to reflect current treatment practice. SAMHSA’s changes would impact roughly 1800 opioid treatment programs and state opioid treatment authorities. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Undetermined | Unfunded Mandates: No |
CFR Citation: 42 CFR 8 | |
Legal Authority: 21 U.S.C. sec. 823(g)(1) |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Yes | Government Levels Affected: State |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: Yes | |
RIN Data Printed in the FR: Yes | |
Agency Contact: Dr. Neeraj Gandotra Chief Medical Officer Department of Health and Human Services Substance Abuse and Mental Health Services Administration 5600 Fishers Lane, 18E67, Rockville, MD 20857 Phone:202 823-1816 Email: neeraj.gandotra@samhsa.hhs.gov |